As Hemmi notes: Some people will lose access. In an emailed statement to WIRED, a spokesperson for Novo Nordisk says, Moving forward, any compounder that mass produces or sells knockoff drugs is breaking the law and compromising patient safety. A spokesperson for Eli Lilly echoed that sentiment, saying via email that the FDA and a federal court have both made clear that compounders must cease production of compounded tirzepatide knockoffs. Anthony Comuzzie, CEO of the Obesity Society, recognizes that there are legitimate access issues to GLP-1 medications, but he worries that some people who have sought out compounded versions may not meet the medical definition of obesity and are using them more casually for weight loss
& Grinspoon, S
Strain isolation and cell-based studies indicate that Ruminococcus_E bovis , which is significantly downregulated in the rumen of ketotic cows, can provide gluconeogenic precursors such as alanine, thereby promoting hepatic glucose production and reducing ketone formation 59
These changes can also cause skin sagging, wrinkling, and volume loss
Rebound appetite When cagrilintide is discontinued, appetite typically returns
